Join us for an insightful workshop tissue engineering and therapeutics featuring Dr. Richard McFarland, ARMI BioFaUSA’s Chief Regulatory Officer as a distinguished speaker. Tissue engineering, a cutting-edge approach to restoring, improving, and replacing damaged tissues and organs, holds immense promise for the future of medicine.
This workshop will delve into the latest scientific advancements through an engaging “science slam” format, where experts will showcase the most recent breakthroughs in tissue engineering. Discover how artificial skin and cartilage, among other engineered tissues, have already received FDA approval, and gain valuable insights into the eight tissue engineered products that have been successfully authorized in the U.S.
Additionally, the event will explore funding and partnering perspectives, shedding light on the investment landscape and the exciting market opportunities that lie ahead. Whether you are a researcher, entrepreneur, or industry professional, this workshop will equip you with valuable knowledge to navigate the tissue engineering landscape effectively.
Finally, it will address regulatory perspectives, providing crucial insights into the regulatory pathways for tissue engineered products.
Don’t miss this unique opportunity to connect with experts, exchange ideas, and stay at the forefront of tissue engineering. Join us at this event and be part of the transformational journey toward improved healthcare through tissue engineering.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
